Global and United States Oral Polio Vaccines (OPV) Market Report & Forecast 2023-2028

Report ID: 1868511 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Oral Polio Vaccines (OPV) Product Introduction
    1.2 Global Oral Polio Vaccines (OPV) Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Oral Polio Vaccines (OPV) Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Oral Polio Vaccines (OPV) Sales in Volume for the Year 2017-2028
    1.3 United States Oral Polio Vaccines (OPV) Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Oral Polio Vaccines (OPV) Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Oral Polio Vaccines (OPV) Sales in Volume for the Year 2017-2028
    1.4 Oral Polio Vaccines (OPV) Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Oral Polio Vaccines (OPV) in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Oral Polio Vaccines (OPV) Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Oral Polio Vaccines (OPV) Market Dynamics
        1.5.1 Oral Polio Vaccines (OPV) Industry Trends
        1.5.2 Oral Polio Vaccines (OPV) Market Drivers
        1.5.3 Oral Polio Vaccines (OPV) Market Challenges
        1.5.4 Oral Polio Vaccines (OPV) Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Oral Polio Vaccines (OPV) Market Segment by Type
        2.1.1 Trivalent OPV
        2.1.2 Bivalent OPV
    2.2 Global Oral Polio Vaccines (OPV) Market Size by Type
        2.2.1 Global Oral Polio Vaccines (OPV) Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Oral Polio Vaccines (OPV) Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Oral Polio Vaccines (OPV) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Oral Polio Vaccines (OPV) Market Size by Type
        2.3.1 United States Oral Polio Vaccines (OPV) Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Oral Polio Vaccines (OPV) Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Oral Polio Vaccines (OPV) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Oral Polio Vaccines (OPV) Market Segment by Application
        3.1.1 Public
        3.1.2 Private
    3.2 Global Oral Polio Vaccines (OPV) Market Size by Application
        3.2.1 Global Oral Polio Vaccines (OPV) Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Oral Polio Vaccines (OPV) Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Oral Polio Vaccines (OPV) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Oral Polio Vaccines (OPV) Market Size by Application
        3.3.1 United States Oral Polio Vaccines (OPV) Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Oral Polio Vaccines (OPV) Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Oral Polio Vaccines (OPV) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Oral Polio Vaccines (OPV) Competitor Landscape by Company
    4.1 Global Oral Polio Vaccines (OPV) Market Size by Company
        4.1.1 Top Global Oral Polio Vaccines (OPV) Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Oral Polio Vaccines (OPV) Revenue by Manufacturer (2017-2022)
        4.1.3 Global Oral Polio Vaccines (OPV) Sales by Manufacturer (2017-2022)
        4.1.4 Global Oral Polio Vaccines (OPV) Price by Manufacturer (2017-2022)
    4.2 Global Oral Polio Vaccines (OPV) Concentration Ratio (CR)
        4.2.1 Oral Polio Vaccines (OPV) Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oral Polio Vaccines (OPV) in 2021
        4.2.3 Global Oral Polio Vaccines (OPV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Oral Polio Vaccines (OPV) Manufacturing Base Distribution, Product Type
        4.3.1 Global Oral Polio Vaccines (OPV) Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Oral Polio Vaccines (OPV) Product Type
        4.3.3 Date of International Manufacturers Enter into Oral Polio Vaccines (OPV) Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Oral Polio Vaccines (OPV) Market Size by Company
        4.5.1 Top Oral Polio Vaccines (OPV) Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Oral Polio Vaccines (OPV) Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Oral Polio Vaccines (OPV) Sales by Players (2020, 2021 & 2022)
5 Global Oral Polio Vaccines (OPV) Market Size by Region
    5.1 Global Oral Polio Vaccines (OPV) Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Oral Polio Vaccines (OPV) Market Size in Volume by Region (2017-2028)
        5.2.1 Global Oral Polio Vaccines (OPV) Sales in Volume by Region: 2017-2022
        5.2.2 Global Oral Polio Vaccines (OPV) Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Oral Polio Vaccines (OPV) Market Size in Value by Region (2017-2028)
        5.3.1 Global Oral Polio Vaccines (OPV) Sales in Value by Region: 2017-2022
        5.3.2 Global Oral Polio Vaccines (OPV) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Oral Polio Vaccines (OPV) Market Size YoY Growth 2017-2028
        6.1.2 North America Oral Polio Vaccines (OPV) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Oral Polio Vaccines (OPV) Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Oral Polio Vaccines (OPV) Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Oral Polio Vaccines (OPV) Market Size YoY Growth 2017-2028
        6.3.2 Europe Oral Polio Vaccines (OPV) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Oral Polio Vaccines (OPV) Market Size YoY Growth 2017-2028
        6.4.2 Latin America Oral Polio Vaccines (OPV) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Oral Polio Vaccines (OPV) Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Oral Polio Vaccines (OPV) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Corporation Information
        7.1.2 Sanofi Description and Business Overview
        7.1.3 Sanofi Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Sanofi Oral Polio Vaccines (OPV) Products Offered
        7.1.5 Sanofi Recent Development
    7.2 GSK
        7.2.1 GSK Corporation Information
        7.2.2 GSK Description and Business Overview
        7.2.3 GSK Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 GSK Oral Polio Vaccines (OPV) Products Offered
        7.2.5 GSK Recent Development
    7.3 Bibcol
        7.3.1 Bibcol Corporation Information
        7.3.2 Bibcol Description and Business Overview
        7.3.3 Bibcol Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Bibcol Oral Polio Vaccines (OPV) Products Offered
        7.3.5 Bibcol Recent Development
    7.4 Serum Institute
        7.4.1 Serum Institute Corporation Information
        7.4.2 Serum Institute Description and Business Overview
        7.4.3 Serum Institute Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Serum Institute Oral Polio Vaccines (OPV) Products Offered
        7.4.5 Serum Institute Recent Development
    7.5 Tiantan Biological
        7.5.1 Tiantan Biological Corporation Information
        7.5.2 Tiantan Biological Description and Business Overview
        7.5.3 Tiantan Biological Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Tiantan Biological Oral Polio Vaccines (OPV) Products Offered
        7.5.5 Tiantan Biological Recent Development
    7.6 Panacea Biotec Ltd
        7.6.1 Panacea Biotec Ltd Corporation Information
        7.6.2 Panacea Biotec Ltd Description and Business Overview
        7.6.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Products Offered
        7.6.5 Panacea Biotec Ltd Recent Development
    7.7 Bio-Med
        7.7.1 Bio-Med Corporation Information
        7.7.2 Bio-Med Description and Business Overview
        7.7.3 Bio-Med Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Bio-Med Oral Polio Vaccines (OPV) Products Offered
        7.7.5 Bio-Med Recent Development
    7.8 Halfkin Bio-Pharmaceuticals
        7.8.1 Halfkin Bio-Pharmaceuticals Corporation Information
        7.8.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
        7.8.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Products Offered
        7.8.5 Halfkin Bio-Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Oral Polio Vaccines (OPV) Industry Chain Analysis
    8.2 Oral Polio Vaccines (OPV) Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Oral Polio Vaccines (OPV) Distributors
    8.3 Oral Polio Vaccines (OPV) Production Mode & Process
    8.4 Oral Polio Vaccines (OPV) Sales and Marketing
        8.4.1 Oral Polio Vaccines (OPV) Sales Channels
        8.4.2 Oral Polio Vaccines (OPV) Distributors
    8.5 Oral Polio Vaccines (OPV) Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Oral Polio Vaccines (OPV) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Oral Polio Vaccines (OPV) Market Trends
    Table 3. Oral Polio Vaccines (OPV) Market Drivers
    Table 4. Oral Polio Vaccines (OPV) Market Challenges
    Table 5. Oral Polio Vaccines (OPV) Market Restraints
    Table 6. Global Oral Polio Vaccines (OPV) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Oral Polio Vaccines (OPV) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Oral Polio Vaccines (OPV) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Oral Polio Vaccines (OPV) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Oral Polio Vaccines (OPV) Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Oral Polio Vaccines (OPV) Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Oral Polio Vaccines (OPV) Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Oral Polio Vaccines (OPV) Sales by Manufacturer, (M Doses), 2017-2022
    Table 14. Global Oral Polio Vaccines (OPV) Sales Share by Manufacturer, 2017-2022
    Table 15. Global Oral Polio Vaccines (OPV) Price by Manufacturer (2017-2022) & (USD/Doses)
    Table 16. Global Oral Polio Vaccines (OPV) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Oral Polio Vaccines (OPV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Polio Vaccines (OPV) as of 2021)
    Table 18. Top Players of Oral Polio Vaccines (OPV) in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Oral Polio Vaccines (OPV) Product Type
    Table 20. Date of International Manufacturers Enter into Oral Polio Vaccines (OPV) Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Oral Polio Vaccines (OPV) Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Oral Polio Vaccines (OPV) Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Oral Polio Vaccines (OPV) Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Oral Polio Vaccines (OPV) Sales by Players, (M Doses), 2020, 2021 & 2022
    Table 26. United States Oral Polio Vaccines (OPV) Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Oral Polio Vaccines (OPV) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Oral Polio Vaccines (OPV) Sales in Volume by Region (2017-2022) & (M Doses)
    Table 29. Global Oral Polio Vaccines (OPV) Sales in Volume Forecast by Region (2023-2028) & (M Doses)
    Table 30. Global Oral Polio Vaccines (OPV) Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Oral Polio Vaccines (OPV) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Oral Polio Vaccines (OPV) Sales in Volume by Country (2017-2028) & (M Doses)
    Table 33. North America Oral Polio Vaccines (OPV) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Oral Polio Vaccines (OPV) Sales in Volume by Region (2017-2028) & (M Doses)
    Table 35. Asia Pacific Oral Polio Vaccines (OPV) Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Oral Polio Vaccines (OPV) Sales in Volume by Country (2017-2028) & (M Doses)
    Table 37. Europe Oral Polio Vaccines (OPV) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Oral Polio Vaccines (OPV) Sales in Volume by Country (2017-2028) & (M Doses)
    Table 39. Latin Americaa Oral Polio Vaccines (OPV) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Oral Polio Vaccines (OPV) Sales in Volume by Country (2017-2028) & (M Doses)
    Table 41. Middle East and Africa Oral Polio Vaccines (OPV) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Sanofi Corporation Information
    Table 43. Sanofi Description and Business Overview
    Table 44. Sanofi Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 45. Sanofi Oral Polio Vaccines (OPV) Product
    Table 46. Sanofi Recent Development
    Table 47. GSK Corporation Information
    Table 48. GSK Description and Business Overview
    Table 49. GSK Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 50. GSK Product
    Table 51. GSK Recent Development
    Table 52. Bibcol Corporation Information
    Table 53. Bibcol Description and Business Overview
    Table 54. Bibcol Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 55. Bibcol Product
    Table 56. Bibcol Recent Development
    Table 57. Serum Institute Corporation Information
    Table 58. Serum Institute Description and Business Overview
    Table 59. Serum Institute Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 60. Serum Institute Product
    Table 61. Serum Institute Recent Development
    Table 62. Tiantan Biological Corporation Information
    Table 63. Tiantan Biological Description and Business Overview
    Table 64. Tiantan Biological Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 65. Tiantan Biological Product
    Table 66. Tiantan Biological Recent Development
    Table 67. Panacea Biotec Ltd Corporation Information
    Table 68. Panacea Biotec Ltd Description and Business Overview
    Table 69. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 70. Panacea Biotec Ltd Product
    Table 71. Panacea Biotec Ltd Recent Development
    Table 72. Bio-Med Corporation Information
    Table 73. Bio-Med Description and Business Overview
    Table 74. Bio-Med Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 75. Bio-Med Product
    Table 76. Bio-Med Recent Development
    Table 77. Halfkin Bio-Pharmaceuticals Corporation Information
    Table 78. Halfkin Bio-Pharmaceuticals Description and Business Overview
    Table 79. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 80. Halfkin Bio-Pharmaceuticals Product
    Table 81. Halfkin Bio-Pharmaceuticals Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Oral Polio Vaccines (OPV) Customers List
    Table 85. Oral Polio Vaccines (OPV) Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oral Polio Vaccines (OPV) Product Picture
    Figure 2. Global Oral Polio Vaccines (OPV) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Oral Polio Vaccines (OPV) Market Size 2017-2028 (US$ Million)
    Figure 4. Global Oral Polio Vaccines (OPV) Sales 2017-2028 (M Doses)
    Figure 5. United States Oral Polio Vaccines (OPV) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Oral Polio Vaccines (OPV) Market Size 2017-2028 (US$ Million)
    Figure 7. United States Oral Polio Vaccines (OPV) Sales 2017-2028 (M Doses)
    Figure 8. United States Oral Polio Vaccines (OPV) Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Oral Polio Vaccines (OPV) Market Share in Global, in Volume (M Doses) 2017-2028
    Figure 10. Oral Polio Vaccines (OPV) Report Years Considered
    Figure 11. Product Picture of Trivalent OPV
    Figure 12. Product Picture of Bivalent OPV
    Figure 13. Global Oral Polio Vaccines (OPV) Market Share by Type in 2022 & 2028
    Figure 14. Global Oral Polio Vaccines (OPV) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Oral Polio Vaccines (OPV) Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Oral Polio Vaccines (OPV) Sales by Type (2017-2028) & (M Doses)
    Figure 17. Global Oral Polio Vaccines (OPV) Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Oral Polio Vaccines (OPV) Price by Type (2017-2028) & (USD/Doses)
    Figure 19. United States Oral Polio Vaccines (OPV) Market Share by Type in 2022 & 2028
    Figure 20. United States Oral Polio Vaccines (OPV) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Oral Polio Vaccines (OPV) Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Oral Polio Vaccines (OPV) Sales by Type (2017-2028) & (M Doses)
    Figure 23. United States Oral Polio Vaccines (OPV) Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Oral Polio Vaccines (OPV) Price by Type (2017-2028) & (USD/Doses)
    Figure 25. Product Picture of Public
    Figure 26. Product Picture of Private
    Figure 27. Global Oral Polio Vaccines (OPV) Market Share by Application in 2022 & 2028
    Figure 28. Global Oral Polio Vaccines (OPV) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Oral Polio Vaccines (OPV) Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Oral Polio Vaccines (OPV) Sales by Application (2017-2028) & (M Doses)
    Figure 31. Global Oral Polio Vaccines (OPV) Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Oral Polio Vaccines (OPV) Price by Application (2017-2028) & (USD/Doses)
    Figure 33. United States Oral Polio Vaccines (OPV) Market Share by Application in 2022 & 2028
    Figure 34. United States Oral Polio Vaccines (OPV) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Oral Polio Vaccines (OPV) Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Oral Polio Vaccines (OPV) Sales by Application (2017-2028) & (M Doses)
    Figure 37. United States Oral Polio Vaccines (OPV) Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Oral Polio Vaccines (OPV) Price by Application (2017-2028) & (USD/Doses)
    Figure 39. North America Oral Polio Vaccines (OPV) Sales in Volume Growth Rate 2017-2028 (M Doses)
    Figure 40. North America Oral Polio Vaccines (OPV) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Oral Polio Vaccines (OPV) Sales in Volume Growth Rate 2017-2028 (M Doses)
    Figure 44. Europe Oral Polio Vaccines (OPV) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Oral Polio Vaccines (OPV) Sales in Volume Growth Rate 2017-2028 (M Doses)
    Figure 51. Asia-Pacific Oral Polio Vaccines (OPV) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Oral Polio Vaccines (OPV) Sales in Volume Growth Rate 2017-2028 (M Doses)
    Figure 63. Latin America Oral Polio Vaccines (OPV) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Oral Polio Vaccines (OPV) Sales in Volume Growth Rate 2017-2028 (M Doses)
    Figure 68. Middle East & Africa Oral Polio Vaccines (OPV) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. U.A.E Oral Polio Vaccines (OPV) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Oral Polio Vaccines (OPV) Value Chain
    Figure 73. Oral Polio Vaccines (OPV) Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Frequently Asked Questions
Oral Polio Vaccines (OPV) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oral Polio Vaccines (OPV) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oral Polio Vaccines (OPV) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Food Grade Seal

Food Grade Seal market is segmented by region (country), players, by Type and by Application. Pla ... Read More

Silage Harvester

Silage Harvester market is segmented by region (country), players, by Type and by Application. Pl ... Read More